Why the study?
Do patient-initiated implantable pacemakers improve rhythm control and reduce hospitalizations in patients with drug-resistant paroxysmal supraventricular tachycardia?
Do patient-initiated implantable pacemakers improve rhythm control and reduce hospitalizations in patients with drug-resistant paroxysmal supraventricular tachycardia?
Patient-initiated radiofrequency pacemakers provided an effective treatment for carefully selected patients with drug-resistant paroxysmal supraventricular tachycardia, reducing hospitalizations and the need for antiarrhythmic drugs.
No takes yet. Share an insight, caveat, or question.
May reduce hospitalizations and drug needs in select refractory PSVT; leaves open confirmation in prospective trials.
Vohra et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: